Showing results (2171-2180 of 3,595) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|November 19, 2011
Chronic hepatitis C infection blocks the ability of dendritic cells to secrete IFN-α and stimulate T-cell proliferationE J Ryan, N J Stevenson, J E Hegarty, et al.Journal of Viral Hepatitis|February 15, 2012
Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbationC-C Chen, P-C Wang, H-W Chang, et al.Journal of Viral Hepatitis|January 12, 2012
Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?M Simón-Talero, M Buti, R EstebanJournal of Viral Hepatitis|January 12, 2012
Steatosis and insulin resistance in response to treatment of chronic hepatitis CF NegroJournal of Viral Hepatitis|January 14, 2012
Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis CF Stickel, B Helbling, M Heim, et al.Journal of Viral Hepatitis|January 14, 2012
Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirinN Reau, F M Hamzeh, E Lentz, et al.Journal of Viral Hepatitis|January 14, 2012
Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patientsE Y Ho, N B Ha, A Ahmed, et al.Journal of Viral Hepatitis|January 14, 2012
The tumour necrosis factor-α-238A allele increases the risk of chronic HBV infection in European populationsM-H Zheng, D-D Xiao, X-F Lin, et al.Journal of Viral Hepatitis|January 14, 2012
Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infectionI Yamada, F Suzuki, N Kamiya, et al.Journal of Viral Hepatitis|January 14, 2012
Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infectionD Miki, W Ohishi, H Ochi, et al.Pageof 360